Class Action Notice for Applied Therapeutics (APLT) Investors

Class Action Notification for Investors in Applied Therapeutics

The Gross Law Firm has put forward a significant notice aimed at the shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT). This notification outlines important developments regarding a class action lawsuit that affects shareholders who invested during a specified class period.

Details of the Class Action Lawsuit

Shareholders who purchased shares of APLT between January 3, 2024, and December 2, 2024, are encouraged to reach out to the law firm to discuss the possibility of being appointed as lead plaintiffs. It’s important to note that you do not need to be appointed as a lead plaintiff in order to partake in any potential recovery from the case.

Class Period Overview

During the set class period, Applied Therapeutics faced major challenges that adversely affected its stock price. On November 27, 2024, the company announced it had received a Complete Response Letter (CRL) concerning its New Drug Application for govorestat, its leading drug candidate. This letter revealed that the FDA had completed its review and could not approve the application in its current form, highlighting deficiencies in the clinical data submitted.

Impact on Stock Prices

This news led to a significant drop in the share value of Applied Therapeutics. On November 26, 2024, the closing market price was at $10.21 per share, but by November 29, 2024, it plummeted to $2.03. This marked an alarming decline of over 80%. Following the disclosure of a warning letter from the FDA on December 2, which pointed out clinical trial issues that contributed to the CRL, the stock continued to drop to $1.69 by December 3, and further down to $1.29 by December 5.

Deadline for Shareholders

Shareholders should act promptly, as the deadline to register for this class action is February 18, 2025. Therefore, it’s crucial for investors to submit their information without delay.

Steps to Follow as a Shareholder

Upon registering as a shareholder who purchased shares of APLT within the designated time frame, you will gain access to a portfolio monitoring software designed to keep you informed about the status of the case. You won't incur any fees or obligations to participate in this action.

Why Choose The Gross Law Firm?

The Gross Law Firm is recognized nationally for its commitment to protecting the rights of investors who have faced losses due to fraudulent activities and misleading corporate practices. Their mission entails holding companies accountable for responsible business conduct and ensuring investor protections against false information that can affect stock prices.

Contact Information

If you wish to learn more or have inquiries, you can reach The Gross Law Firm at their office located at 15 West 38th Street, 12th floor, New York, NY 10018, or contact them by phone at (646) 453-8903. They are dedicated to assisting investors through these challenging circumstances.

Frequently Asked Questions

What is the purpose of the class action against Applied Therapeutics?

The class action seeks to provide recovery for shareholders who experienced losses between the specified dates due to misleading information regarding the company's drug application.

How can I register for the class action?

Shareholders can register by providing their information through the communication issued by the Gross Law Firm before the deadline of February 18, 2025.

What should I do if I purchased APLT shares?

If you bought shares during the class period, you should contact the Gross Law Firm to ensure that your rights are protected and to discuss your eligibility to recover any losses.

Is there any cost to participate in the class action?

No, there is no cost or obligation for shareholders to participate in this class action against Applied Therapeutics.

What happens after I register?

After registration, you will receive updates regarding the status of the case and be informed of any significant developments through the monitoring software provided.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. If any of the material offered here is inaccurate, please contact us for corrections.